SCHEMBL21381489

SCHEMBL21381489

Fc1ccc(-c2c[c]cn2Cc2ccc3c(c2)OCO3)cc1

nearest known ligand 0.55

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.50
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ THRB P10828 1/20 0.44
▸ CMA1 P23946 1/20 0.44
▸ FAAH O00519 1/20 0.43
▸ MAPT P10636 4/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ GAA P10253 1/20 0.42
▸ MAPK1 P28482 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20379142 0.88 SMN1; SMN2 (0.49) KDM4ESMN1; SMN2THRBCMA1MAPT
SCHEMBL20379138 0.88 MAPT (0.49) KDM4ESMN1; SMN2THRBCMA1MAPT
SCHEMBL21382022 0.88 CMA1 (0.44) KDM4ESMN1; SMN2THRBCMA1FAAH
SCHEMBL21381493 0.88 SMN1; SMN2 (0.47) KDM4ESMN1; SMN2THRBCMA1MAPT
SCHEMBL21381467 0.87 SMN1; SMN2 (0.46) SMN1; SMN2CMA1FAAHALDH1A1KMT2A
SCHEMBL20379164 0.85 TRPV6 (0.47) KDM4ESMN1; SMN2THRBCMA1MAPT
SCHEMBL28878851 0.81 KDM4E (0.53) KDM4ESMN1; SMN2THRBCMA1FAAH
SCHEMBL21373634 0.77 CMA1 (0.50) KDM4ESMN1; SMN2CMA1MAPTMAPK1
SCHEMBL21381478 0.76 THRB (0.52) KDM4ESMN1; SMN2THRBCMA1FAAH
SCHEMBL21373520 0.76 KDM4E (0.41) KDM4ECMA1MAPTALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3768673-A1 COMPOUNDS FOR TREATING CNS- AND NEURODEGENERATIVE DISEASES ETH Zurich (CH) 2021-01-27 — — EP claimed
WO-2019179890-A1 COMPOUNDS FOR TREATING CNS- AND NEURODEGENERATIVE DISEASES ETH ZURICH (CH) 2019-09-26 — — WO claimed
CN-116462666-A Cytoprotective compounds and uses thereof 瑞士苏黎世联邦理工学院 2023-07-21 — — CN disclosed
EP-3768673-A1 COMPOUNDS FOR TREATING CNS- AND NEURODEGENERATIVE DISEASES ETH Zurich (CH) 2021-01-27 — — EP disclosed
WO-2019179890-A1 COMPOUNDS FOR TREATING CNS- AND NEURODEGENERATIVE DISEASES ETH ZURICH (CH) 2019-09-26 — — WO disclosed
Send feedback